Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study have?
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study has 76 citations in the OpenAlex counts ScholarIQ stores.
When was Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study published?
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study has 2019 year in the ScholarIQ index.
What is the open-access status of Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study?
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study has gold oa status in the ScholarIQ index.
What is the DOI of Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study?
The DOI for Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study is on the source record.
What is the PMID of Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study?
The PMID for Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study is on the source record.
What is the OpenAlex record for Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study?
The OpenAlex for Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study is on the source record.